Page last updated: 2024-12-06

4-acetoxy-4-androstene-3,17-dione

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

4-acetoxy-4-androstene-3,17-dione: aromatase (estrogen synthetase) inhibitor [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID43710
SCHEMBL ID1553350
MeSH IDM0078817

Synonyms (11)

Synonym
4-(acetyloxy)androst-4-ene-3,17-dione
4-acetoxy-4-androstene-3,17-dione
androst-4-ene-3,17-dione, 4-hydroxy-, acetate (ester)
androst-4-ene-3,17-dione, 4-(acetyloxy)-
brn 5126061
4-androsten-4-ol-3,17-dione acetate
[(8r,9s,10r,13s,14s)-10,13-dimethyl-3,17-dioxo-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-4-yl] acetate
61630-32-8
SCHEMBL1553350
DTXSID00210647
3,17-dioxoandrost-4-en-4-yl acetate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (92.31)18.7374
1990's0 (0.00)18.2507
2000's1 (7.69)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (13.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (86.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]